The global bipolar disorder drugs market is anticipated to grow at a considerable CAGR of during the forecast period. Several major players operating within the bipolar disorder drugs market are inclined towards the adoption of various strategic alliances such as acquisitions, partnerships, collaborations, and the launching of new drugs and vaccines to provide advanced treatment for bipolar disorder treatment globally. This is the primary and major factor that is supporting the growth of the market.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/bipolar-disorder-drugs-market
For instance, In June 2021, USFDA approved a new drug option to treat patients with schizophrenia and bipolar disorder I which is a combination of olanzapine and semi orphan and can be taken once daily. Several other drugs are in the pipeline which will be a combination of old drugs with new drug type that are intended for the treatment of bipolar disorder more effectively. Further, in March 2019, VistaGen Therapeutics, a biopharmaceutical company developed a new general medicine to treat various bipolar disorders including depression, social anxiety disorder, and central nervous system disease. in March 2019, the US Food and Drug Administration (USFDA) approved Johnson & Johnson Healthcare nasal spray antidepressant for people resistant to other treatments. The drug esketamine nasal spray works within an hour.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Drug type
- By Distribution channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape – Allergan, AstraZeneca, Eli Lilly and Co., GlaxoSmithKline, Pfizer Inc., and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Bipolar disorder drugs Market Report Segment
By Drug Type
- Mood Stabilizers
- Anti-Depressant Drug
- Anti-Psychotic Drug
- Anti-Anxiety Drug
By Distribution Channel
- Online Pharmacies
- Offline Pharmacies
A full report of Bipolar Disorder Drugs Market is available at: https://www.omrglobal.com/industry-reports/bipolar-disorder-drugs-market
Bipolar Disorder Drugs Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Alkermes
- Allergan
- BioXcel Therapeutics Inc.
- Bristol-Myers Squibb Co.
- Celon Pharma SA
- Eli Lilly and Co.
- Intra-Cellular Therapies, Inc.
- Jina Pharma
- LUNDBECK A/S
- Johnson & Johnson Healthcare
- Merck & Co., Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
